Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Performance of the Bronchoalveolar Lavage FluidAspergillusGalactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1281Source: DataRank Database

Performance of the Bronchoalveolar Lavage FluidAspergillusGalactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study is a research paper published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 78 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access78 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.19)OA: bronzeTopics (58)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Juergen Prattes ORCID,Johanna Frank,Birgit Spieß ORCID,Sanjay R. Mehta ORCID,Tobias Boch ORCID

Live enrichment

PubMed:32866234 OpenAlex:https://openalex.org/W3081777061

National Institutes of Health

Grant: MH113477

National Institutes of Health

Grant: UL1TR001442

National Institutes of Health

Grant: 2UL1TR001442-06

UC San Diego Clinical and Translational Research Institute

NIMH NIH HHS

Grant: R21 MH113477

Pfizer

FWCI

1.19

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1281/34030637/ciaa1281.pdf

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1281/34030637/ciaa1281.pdf

publisherhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1281/34030637/ciaa1281.pdf

publisherhttp://academic.oup.com/cid/article-pdf/73/7/e1737/40510996/ciaa1281.pdf

journalhttps://doi.org/10.1093/cid/ciaa1281

Fields of Study

Antifungal resistance and susceptibilityFungal Infections and StudiesInfectious Diseases and Mycology03 medical and health sciences0303 health sciencesAntigens, FungalAspergillusBronchoalveolar Lavage FluidGalactoseHumansInvasive Pulmonary AspergillosisMannansRetrospective StudiesSensitivity and Specificity

MeSH Terms

Antigens, FungalAspergillusBronchoalveolar Lavage FluidGalactoseHumansMannansRetrospective StudiesSensitivity and SpecificityInvasive Pulmonary Aspergillosis

Keywords

GalactomannanBronchoalveolar lavageMedicineAspergillosisAspergillusMulticenter studyAspergillus fumigatusPathologyMicrobiologyImmunologyLungInternal medicineAntigens, FungalClinical Sciences610intensive care unitMedical and Health SciencesSensitivity and SpecificityMannansRare DiseasesClinical ResearchHumansautoimmune diseasesAntigensRetrospective StudiesInvasive Pulmonary AspergillosisBiomedical and Clinical Sciencesrespiratory diseasesGalactosesolid organ transplant recipientsBiological SciencesInfectious DiseasesFungalhematologic malignancyBronchoalveolar Lavage Fluid

Sustainable Development Goals

SDG 3: 3. Good health